Orphazyme postpones 2021 annual report

Beleaguered biotech company Orphazyme will publicize its full-year financial figures on April 7 instead of the previously announced date, March 15.
Anders Vadsholt, CEO of Orphazyme | Photo: Orphazyme / PR
Anders Vadsholt, CEO of Orphazyme | Photo: Orphazyme / PR
by CHRISTIAN BUNDGAARD, translate by daniel pedersen

Onlookers and shareholders who want to get their hands on the annual report from biotech firm Orphazyme, which has been besieged by bad news in recent times, will have to wait a little longer.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading